Glucose deprivation in tuberous sclerosis complex-related tumors
<p>Abstract</p> <p>Background</p> <p>Cancer cells possess unique metabolic phenotypes that are determined by their underlying oncogenic pathways. Activation of the PI3K/Akt/mTOR signaling cascade promotes glycolysis and leads to glucose-dependence in tumors. In particul...
Main Authors: | Jiang Xiuyun, Kenerson Heidi L, Yeung Raymond S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | http://www.cellandbioscience.com/content/1/1/34 |
Similar Items
-
Genetics of tuberous sclerosis complex: implications for clinical practice
by: Caban C, et al.
Published: (2016-12-01) -
Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
by: Cabrera-López Cristina, et al.
Published: (2012-11-01) -
Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer
by: Ryan W. Holloway, et al.
Published: (2021-06-01) -
2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control
by: Jong M. Rho, et al.
Published: (2019-04-01) -
mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01)